Systematic clinical and pharmacological monitoring of a PEG-asparaginase biogeneric (HAMSYL®) in paediatric patients with newly-diagnosed acute lymphoblastic leukaemia
Pediatr Hematol Oncol. 2023; 8(4):S48. doi: 10.1016/j.phoj.2023.10.122
https://www.sciencedirect.com/science/article/pii/S2468124523001821?via%3Dihub
